News
HAE
77.29
-0.43%
-0.33
Haemonetics Price Target Maintained With a $84.00/Share by BTIG
Dow Jones · 2d ago
BTIG Reiterates Buy on Haemonetics, Maintains $84 Price Target
Benzinga · 2d ago
Analysts Conflicted on These Healthcare Names: Haemonetics (HAE) and Health Catalyst (HCAT)
TipRanks · 2d ago
3 Profitable Stocks We Find Risky
Barchart · 2d ago
Weekly Report: what happened at HAE last week (0615-0619)?
Weekly Report · 6d ago
Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Immix Biopharma (IMMX) and Haemonetics (HAE)
TipRanks · 06/17 12:01
BTIG Reiterates Buy on Haemonetics, Maintains $84 Price Target
Benzinga · 06/17 10:00
Haemonetics management to meet virtually with BTIG
TipRanks · 06/16 18:10
Haemonetics Price Target Raised to $85.00/Share From $70.00 by Mizuho
Dow Jones · 06/15 17:36
Haemonetics Is Maintained at Outperform by Mizuho
Dow Jones · 06/15 17:36
Mizuho Maintains Outperform on Haemonetics, Raises Price Target to $85
Benzinga · 06/15 17:26
Haemonetics price target raised to $85 from $70 at Mizuho
TipRanks · 06/15 11:14
Weekly Report: what happened at HAE last week (0608-0612)?
Weekly Report · 06/15 09:47
Is Haemonetics’ (HAE) Apheresis Reorg Quietly Redefining Its Competitive Edge in Medical Devices?
Simply Wall St · 06/11 12:41
Weekly Report: what happened at HAE last week (0601-0605)?
Weekly Report · 06/08 09:45
Haemonetics: Buy Rating Reiterated as New Apheresis Reporting Boosts Transparency; $80 Price Target Maintained
TipRanks · 06/08 09:05
Is Haemonetics (HAE) Stock Price Reflecting Its Recent 29% Monthly Surge Accurately
Simply Wall St · 06/07 04:31
Haemonetics Unveils New Two-Segment Financial Reporting Structure
TipRanks · 06/05 11:09
Weekly Report: what happened at HAE last week (0525-0529)?
Weekly Report · 06/01 09:47
Haemonetics Is Maintained at Neutral by Citigroup
Dow Jones · 05/28 20:12
More
Webull provides a variety of real-time HAE stock news. You can receive the latest news about Haemonetics Corp Mass through multiple platforms. This information may help you make smarter investment decisions.
About HAE
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.